Wenxi Wang | Rewards & Recognition | Best Researcher Award

Posted on by Human Resources Management

Dr. Wenxi Wang | Rewards & Recognition | Best Researcher Award

Dr. Wenxi Wang | Department of Radiation Oncology, Cancer Hospital Chinese Academy of Medical Sciences, Shenzhen Center | China

Dr. Wenxi Wang is a dedicated researcher and clinician specializing in oncology, currently based at the Department of Radiation Oncology, Cancer Hospital Chinese Academy of Medical Sciences, Shenzhen Center. With prior experience at the Winship Cancer Institute of Emory University in the U.S., Dr. Wang bridges international research excellence with clinical practice. His work encompasses translational cancer research, particularly in the mechanisms of tumor progression, immune regulation, and therapeutic response. He has made significant contributions to understanding the VIP-VPAC signaling pathway and its implications in melanoma and pancreatic cancer. A prolific author, Dr. Wang has published in high-impact journals and collaborates actively across global institutions. His scientific rigor, commitment to improving cancer outcomes, and cross-disciplinary approach make him a rising star in oncology research.

Publication Profile:

Orcid 

✅ Strengths for the Award:

  1. High-Impact Publications

    • Published in leading Q1 journals such as Cancer Letters (IF: 9.1) and Cancer Research.

    • Research focuses on critical cancer pathways including VIP-VPAC signaling, a novel and translationally promising area in oncology.

  2. Strong Research Productivity

    • Multiple first-author and co-author publications spanning melanoma, pancreatic cancer, head & neck cancers, and esophageal cancer.

    • Demonstrates consistency in publishing meaningful and diverse research from 2018 through 2025.

  3. Translational and Clinical Relevance

    • Focuses on mechanisms that bridge molecular oncology and therapeutic outcomes.

    • Contributes directly to understanding tumor immunosuppression and metastasis, with implications for targeted therapy.

  4. International Experience

    • Previously affiliated with Emory University’s prestigious Winship Cancer Institute (USA), strengthening his global research exposure.

    • Currently active in a key cancer research institution in China, enabling him to collaborate across borders.

  5. Collaboration & Team Science

    • Works with international multidisciplinary teams.

    • Contributed to projects with experts in immunology, pathology, and medical oncology.

🛠️ Areas for Improvement:

  1. Grant Leadership

    • It is unclear whether Dr. Wang has served as a Principal Investigator (PI) or led funded research independently. Leading high-value grants would further boost his profile.

  2. Clinical Trial Involvement

    • While his work is translational, direct involvement in designing or leading clinical trials would elevate impact toward patient care.

  3. Academic Leadership & Recognition

    • More visibility through invited keynote talks, committee memberships, or professional society leadership would demonstrate his growing stature in the field.

🎓 Education:

Dr. Wenxi Wang received his foundational medical and research training in China, followed by advanced oncological research experience in the United States. He obtained his M.D. or Ph.D. (exact degree not specified, assumed from context) with a focus on oncology-related biomedical sciences. Dr. Wang’s education includes rigorous academic training in both clinical medicine and translational cancer research. His international exposure, notably at Emory University’s Winship Cancer Institute, enhanced his skills in molecular oncology, cancer immunology, and clinical research design. Dr. Wang has continuously pursued professional development through participation in academic conferences, collaborative studies, and publication in peer-reviewed journals. His diverse educational background has empowered him to integrate benchside discoveries into bedside applications, fostering a translational research mindset crucial for innovation in cancer treatment.

💼 Experience:

Dr. Wenxi Wang currently serves in the Department of Radiation Oncology at the Cancer Hospital Chinese Academy of Medical Sciences, Shenzhen Center. Formerly, he conducted advanced research in the Department of Hematology and Medical Oncology at the Winship Cancer Institute of Emory University, USA. He has accumulated a broad range of experience in clinical oncology, laboratory research, and academic publishing. His expertise spans tumor immunology, molecular signaling pathways, and therapeutic response evaluation. Dr. Wang has played leading roles in collaborative cancer studies involving melanoma, pancreatic cancer, and squamous cell carcinoma. His exposure to both Eastern and Western medical research systems enhances his ability to lead multidisciplinary teams and drive impactful cancer investigations. With growing recognition in the scientific community, Dr. Wang is contributing significantly to bridging clinical oncology and laboratory-based research.

🔬 Research Focus:

Dr. Wenxi Wang’s primary research focus is on understanding the molecular and immunological underpinnings of cancer progression and therapy resistance. A key area of his investigation is the vasoactive intestinal peptide (VIP) and VPAC receptor signaling pathway, which he has shown to play a pivotal role in promoting tumor growth and immune evasion in cancers such as melanoma and pancreatic adenocarcinoma. His studies explore how targeting these pathways can suppress metastasis and enhance immune response. In addition, Dr. Wang has examined prognostic biomarkers in oral cancers and the role of non-coding RNAs, such as circular RNAs and PVT1, in tumor development. His work emphasizes translational approaches, aiming to translate bench-side molecular insights into actionable clinical therapies. Through his interdisciplinary projects and multi-institutional collaborations, Dr. Wang seeks to improve diagnostic precision and personalize cancer treatment strategies.

📚 Publications Top Notes:

  1. 🧬 Targeting the VIP-VPAC Pathway in Melanoma Models Inhibits Tumor Growth and Liver Metastasis

  2. 🧫 VPAC2 Receptor Signaling Promotes Growth and Immunosuppression in Pancreatic Cancer

  3. 👅 Prognostic Factors in Surgically Treated Tongue Squamous Cell Carcinoma in Stage T1-2N0-1M0: A Retrospective Analysis

  4. 🔁 PVT1 Promotes Cancer Progression via MicroRNAs

  5. 🌀 Circular RNAs (circRNAs) in Cancer

  6. ⚙️ Roles of PTEN Inactivation and PD-1/PD-L1 Activation in Esophageal Squamous Cell Carcinoma 

📝 Conclusion:

Dr. Wenxi Wang is an exceptionally strong candidate for a Best Researcher Award. He combines scientific rigor with international training, impactful publications, and a clear focus on clinically relevant cancer biology. His contributions to the VIP-VPAC pathway in immuno-oncology are not only novel but also timely in the context of cancer immunotherapy. With additional growth in research leadership and clinical translation, Dr. Wang is on a trajectory toward becoming a globally recognized expert in oncology.

 

Luo Jin | Leadership Development | Best Researcher Award

Posted on by Human Resources Management

Mr. Luo Jin | Leadership Development | Best Researcher Award

Mr. Luo Jin | Lanzhou Veterinary Research Institute，Chinese Academy of Agricultural Sciences, | China

Luo Jin, born on October 3, 1979, in Lanzhou, Gansu, China, is a dedicated researcher in veterinary parasitology, focusing particularly on ticks and tick-borne diseases. With over a decade of experience in molecular biology and immunological techniques, he has contributed significantly to the understanding of pathogen-tick interactions. Currently serving as an Associate Researcher, Luo Jin has published widely in international journals and has demonstrated leadership in scientific innovation, especially in microRNA research and third-generation sequencing. He is affiliated with the Chinese Academy of Agricultural Sciences (CAAS) and continues to push the boundaries of parasitological research, particularly in preventive veterinary medicine. His scholarly contributions and commitment to tackling parasitic threats make him a strong candidate for the Best Researcher Award.

Publication Profile:

Scopus

✅ Strengths for the Award:

  1. Strong Research Output
    Luo Jin has consistently published in reputable, peer-reviewed journals such as FASEB Journal, Pathogens, Frontiers in Immunology, and Veterinary Parasitology, with multiple publications as first or corresponding author.

  2. Innovative Research Focus
    His work on microRNAs, SHERLOCK diagnostics, nanoparticle-based biosensors, and next-gen sequencing in tick-pathogen studies addresses emerging threats in veterinary parasitology and zoonotic diseases.

  3. Interdisciplinary Expertise
    Combines molecular biology, immunology, parasitology, and bioinformatics—crucial for developing new diagnostics and understanding vector-pathogen dynamics.

  4. International Relevance
    Research topics like Rickettsiales, Theileria, and tick-borne disease detection are globally significant, with practical applications in animal health and agriculture.

  5. Longevity and Commitment
    With over a decade of experience in the field and a consistent research trajectory since 2011, he brings both depth and continuity to his contributions.

⚠️ Areas for Improvement:

  1. Clarity in Role Designation
    There is ambiguity around his current designation. While listed as a “Graduate Student,” his CV reflects the experience and publication record of a seasoned Associate Researcher. Clarifying this may improve perception of academic status.

  2. Awards and Recognition
    Although the research output is strong, listing specific awards, grants, fellowships, or keynote speaker roles would help showcase external recognition of his work.

  3. Mentorship and Leadership
    Including information on training of students, project leadership, or collaboration management would further strengthen his profile for a “Best Researcher” title.

🎓 Education:

Luo Jin pursued his academic journey with a strong focus on veterinary sciences. He completed his PhD in Veterinary Medicine from Nanjing Agricultural University in 2018, where he deepened his expertise in tick-borne diseases and molecular diagnostics. Prior to his doctoral studies, he obtained his Master’s degree in Preventive Veterinary Medicine from Gansu Agricultural University (2008–2011), where he built a solid foundation in animal health and disease prevention. His graduate and postgraduate education has been closely aligned with research in molecular parasitology and veterinary microbiology. Throughout his academic career, he has combined practical fieldwork with advanced laboratory research, contributing to significant developments in diagnostic tools and vector-pathogen interaction mechanisms. His strong academic background and consistent focus on the interface between vector biology and molecular diagnostics highlight his dedication to science and public health.

💼 Experience:

Luo Jin has been working as an Associate Researcher since December 2011, focusing on the regulation mechanisms of tick development and pathogen transmission. At CAAS, he has employed molecular biology and immunological techniques to study tick-borne diseases and microRNA functions in vectors. He has led and collaborated on numerous research projects, including cutting-edge developments in SHERLOCK assay diagnostics and nanoparticle-based biosensors. Luo has played a pivotal role in characterizing novel microRNAs, investigating the pathogen community in ticks, and evaluating acaricide efficacy. His interdisciplinary approach spans veterinary parasitology, entomology, molecular biology, and immunology. He is recognized for his rigorous experimental methodology and impactful publications. His continued presence in the field over more than a decade has allowed him to mentor students and collaborate internationally, enhancing both academic and practical understanding of vector-borne diseases.

🔬 Research Focus:

Luo Jin’s research centers on tick biology, tick-pathogen interactions, and the development of advanced molecular diagnostics for tick-borne diseases. His key interests include the regulation of gene expression via microRNAs in tick vectors, understanding the micropathogen communities in various tick species, and evaluating the effectiveness of anti-parasitic agents like fipronil. He has also worked extensively on loop-mediated isothermal amplification (LAMP) techniques, nanoparticle-based detection, and SHERLOCK assays for rapid field diagnostics. Luo Jin’s work bridges the gap between molecular parasitology and practical veterinary applications, offering innovative solutions to long-standing problems in animal and zoonotic health. His research significantly contributes to improved disease surveillance, early detection, and control of vector-borne diseases in both domestic animals and wildlife, particularly in China’s rural and pastoral regions.

📚 Publications Top Notes:

  1. 🧬 Microbial Pathogen Community in Ornithodoros lahorensis (Acari: Argasidae) in China – FASEB Journal, 2025

  2. 🧪 Role of Recognition MicroRNAs in Haemaphysalis longicornis and Theileria orientalis Interactions – Pathogens, 2024

  3. 🩸 A Novel MicroRNA and the Target Gene TAB2 Regulate Blood Sucking and Spawn Rate in Hyalomma asiaticum – Front Immunol, 2022

  4. 🧫 Micropathogen Community Identification in Ticks Using Third-Generation Sequencing – Int J Parasitol Parasites Wildl, 2021

  5. 🔬 MicroRNA-1 Expression and Function in Hyalomma anatolicum anatolicum Ticks – Front Physiol, 2021

  6. 🧯 Dynamic MicroRNA Analysis Across Life Stages of Rhipicephalus microplus by High-Throughput Sequencing – Pathogens, 2022

  7. 🧬 Characterization of an MLP Homologue from Haemaphysalis longicornis Ticks – Pathogens, 2020

  8. ⚗️ Swift Detection of Theileria annulata Using SHERLOCK Assay – Veterinary Parasitology, 2025

  9. 🐫 Molecular Insights into Rickettsiales in Camels and Ticks; Accidental Colpodella sp. Detection – Veterinary Microbiology, 2025

  10. 🧫 Differential Detection of Ovine Theileria via LAMP and Nanoparticle Biosensor – Veterinary Parasitology, 2025

🧾 Conclusion:

Dr. Luo Jin is a highly competent and innovative researcher in the field of veterinary parasitology. His substantial contributions in the study of ticks and tick-borne diseases using cutting-edge molecular tools demonstrate both scientific rigor and real-world application. While more visibility through awards and professional titles would further support his nomination, the breadth, quality, and impact of his research make him a strong and deserving candidate for the Best Researcher Award.